Wednesday, February 21, 2018

Petrogress, Inc. (PGAS) Delivering Shareholder Value by Negotiating Partnerships and Maximizing ROI

  • Negotiated partnerships provide PGAS, through its subsidiaries, with growth in the energy field and expansion into Nigeria and Cypress, Greece
  • Physical trading in oil commodities and logistics is the company’s core business; it makes strategic investments, then operates subsidiaries separately as standalone businesses, leveraging transactions with other company sectors and third parties
  • Company also owns and operates a fleet of tankers through a series of Marshall Islands-based subsidiaries that provide sea transportation for oil and liquefied natural gas
Petrogress, Inc. (OTC: PGAS) is growing and maximizing shareholder value by negotiating partnerships, such as those in Nigeria and Cypress (Greece), while also planning for expansion in its tanker business and oil commodities and liquefied natural gas sea transportation (http://ibn.fm/8qfQG).
Most recently, the company’s subsidiary, Petrogress Int’l LLC (“PIL”), entered into a partnership agreement with A&E Petroleum Co. to jointly form and operate a corporation to be named P&A Nigeria Oil Co. Limited (“PANOC”). The combined company’s stated goal is to engage in oil and gas opportunities in Nigeria while also operating storage tank facilities, providing sea transportation and distribution, and facilitating the sale of gas, oil and other petroleum products (http://ibn.fm/5Z6G4).
In a news release, Christos P. Traios, CEO of Petrogress, said, “Our companies’ combined facilities, assets and services are not only expected to provide for enhanced revenue streams, but also ensure our future in this important international market.”
PGAS is a New York-based, fully integrated oil and natural gas energy company with offices in Piraeus, Greece, and Tema, Ghana. PGAS holds subsidiaries, including Petrogress Co. Limited, Patronav Carriers LLC, and Petrogress Oil & Gas Energy Inc. Petrogress’ vision is to be a vertically-integrated energy company. To achieve a more focused approach in management and enable these subsidiaries to pursue individual growth strategies, the company is separating its shipping business and petroleum sales.
The company is also divided into distinct groups. Its upstream group consists of oil resources and exploration. The midstream group represents its product fleet carriers. Its downstream group features its refinery and finished products. Finally, its liquefied group hosts its liquefied natural gas (LNG) sea transportation operations.
For more information, visit the company’s website at www.PetrogressInc.com
Let us hear your thoughts: Petrogress, Inc. Message Board
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Imaging3, Inc. (IGNG) Proprietary Technology Revolutionizing the Imaging Space

  • Company successfully emerges from three-year bankruptcy process to relaunch its proprietary imaging system and once again seek FDA approval
  • Medical imaging industry is expected to grow to more than $55 billion by 2025
  • The Dominion VI SmartScan™ has virtually infinite potential applications not only for medical imaging and diagnostics, but also in multiple other industries
Imaging3, Inc. (OTCQB: IGNG), a development stage company targeting disruptive technologies in the medical imaging industry, is set to revolutionize the market via proprietary technology offering significant advancements in real-time 3D imaging. The unique technology could prove to be a game changer in the growing medical imaging market, which is expected to reach $55.7 billion worldwide by 2025 as a result of an exponential increase in the use of portable diagnostic devices and the growing prevalence of chronic and sedentary lifestyle diseases (http://ibn.fm/LCXqA).
Founded in 1993, Imaging, Inc. has successfully overcome some difficult challenges to pursue a 510K with the Food and Drug Administration. The Burbank, California-based company might sound familiar to seasoned investors, as it was a popular stock with more than 14,000 investors trading a few years ago. Its lead product and proprietary technology, the Dominion VI SmartScan™, is a patented fluoroscopic device with the capability of producing real-time 3D images, including multi-axis slice through views like a CT, but much faster and with significantly lower radiation exposure to patients. The system is fully portable and works off of any standard 110-volt energy source. In addition to imaging human parts, the Dominion has also imaged agricultural products over the past few months. These images are available on the company’s website (http://ibn.fm/wc2i6).
The Dominion was developed nearly 10 years ago, when Imaging3 was primarily focused on refurbishing C-arms, the fluoroscopes that have been the standard in the imaging industry over the past 40 years. Created with detailed knowledge of how fluoroscopes work and how they could be significantly improved, the Dominion differs from standard C-arms, as it has an O-ring design. The O-shape allows the “eye” – the cone x-ray which emits the low-level radiation – to entirely encircle the target subject or object. During that revolution movement, which can happen as quickly as one revolution per second, the eye is able to take multiple images. The standard approach is one image per degree for 360 degrees, but the number could be higher if required. The images are then assembled into a 3D image, which is displayed via proprietary software. Users can view the image in both 2D and 3D, and they can rotate it to view it from different angles, as well as slice through it in any direction.
The near-term potential uses for the Dominion VI SmartScan™ are virtually infinite, with opportunities available wherever a very fast (one second of imaging time), portable, low-radiation device that can display images like an x-ray or a CT would be to the benefit of a patient or health care provider. Obvious examples include the emergency room for triaging patients, in sports medicine clinics or sporting facilities, in any community in the U.S. or abroad where access to a CT is not readily available or the costs are prohibitive, and in settings where getting a better 3D view of a part of the body can enable the health care provider to do a better job or monitor progress. Additionally, there is significant potential for the device to aid in real-time imaging for minimally-invasive surgery.
The Imaging3 team is confident that it can revolutionize the imaging space with the Dominion VI SmartScan™. The company has already been approached by several industries outside of the medical arena, with security, agriculture, food, transportation and veterans’ organizations each expressing interest in the product.
Imaging3’s work on the revolutionary device several years ago raised a great deal of attention in the industry, and hopes for FDA approval were high. However, the company’s 510K submission was rejected at the time because it failed to provide adequate support to justify claims that exceeded the capabilities of the devices submitted as predicates — comparable devices used in the 510K process. Furthermore, it was discovered that the company’s founder and CEO had committed fraud by not divulging negative FDA feedback to the directors and officers of the company. As a result, the company was forced to seek protection under federal bankruptcy laws.
The company worked through a three-year bankruptcy process and a Securities and Exchange Commission-mandated self-remediation, both of which were completed last year. In November of 2017, the company received a letter from the Division of Corporate Finance of the SEC stating that it, at that time, had no further comments on the company’s post-bankruptcy periodic reports. With that behind it, the company once again focused on preparing the Dominion for FDA review. The company completed the first half of the FDA preparation last year by enlisting one of the leading regulatory consulting companies to conduct an evaluation of the Dominion software. The hardware evaluation, expected to include hazard testing and take roughly three months, is yet to be completed. Once these assessments are finalized, the company will compile the new 510K and submit for review by the FDA. The company hopes to file in the first half of the year.
Subsequent to its emergence from bankruptcy and completion of the SEC self-remediation process, the Imaging3 board recognized the need to start building out a team capable of managing the FDA 510K process to successful completion. With 30 years of health care experience in pharmaceutical, biotech and device companies, including management of public companies listed on the OTC, new CEO John Hollister is prepared to lead this effort. Last month, Hollister and Imaging3 announced the formation of a scientific advisory board, with the first two members being well-respected and experienced radiologists.
Parallel to its FDA efforts, Imaging3 will be busy assessing which of the many potential markets will be the first target for its proprietary technology, while also focusing on designing the final product. The current working model is a prototype that facilitates testing and development, but it is not meant for final production. The company’s management believes that these efforts will result in the first commercial placements in the first quarter of 2019.
For more information, visit the company’s website at www.Imaging3.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Skinvisible, Inc. (SKVI) Aims to Increase Shareholder Value through Proposed Deal with Quoin

  • Drug delivery platform ideal for M&A-driven growth
  • $80 billion global dermatology market
  • $30 billion global over-the-counter skincare market
  • Half of the 100 million surgeries performed in the U.S. require post-surgical pain medication, according to Transparency Market Research report
If history repeats itself, as we are often told, then Skinvisible, Inc.’s (OTCQB: SKVI) proposed deal with Quoin Pharmaceuticals Limited (“Quoin”) could increase shareholder value after execution. In late 2017, the company announced its plan to merge with Quoin, a marriage made in heaven that combines Skinvisible’s virtues as a drug delivery developer with Quoin’s position as a producer of post-surgical pain products that replace or diminish opioid use (http://ibn.fm/GEuCN). Over the past two decades, mergers in the pharmaceutical industry have generally resulted in positive returns to shareholders, and today’s market leaders are the ones that have been most active in mergers and acquisitions.
There are many reasons why a merger may make sense. Taking over a rival, for example, means acquiring that rival’s market share and most, if not all, of its revenues. If product lines or business divisions overlap, costs can be cut and synergies exploited. In addition, purchasing a rival or merging with one may mean the acquisition of exciting new products at a much-reduced cost. It may cost the acquirer less to buy the target (and its product line) than to attempt to develop similar products in-house. Also, borrowing costs matter. If interest rates are low and likely to rise, now might be the time to borrow and spend. These are all good rationales for corporate consolidations. However, ‘growth is the main driver for most M&A deals: not just growth in drug distribution scale or earnings growth through cost cutting, but in revenues—and especially share price’, according to McKinsey & Company (http://ibn.fm/7sWhQ).
Skinvisible is ideally poised to grow by acquisition, since its core business revolves around a drug delivery methodology that’s applicable to a wide range of topical products. Such ‘platform companies’ have a bright future, since they are enablers rather than competitors to other drug companies. Hedge fund manager Bill Ackman, the founder of Pershing Square Capital Management, opined, ‘“platform companies”—those that grow through bolt-on acquisitions—enrich their shareholders with each new deal…’ (http://ibn.fm/LdErS). If that is to be believed, there’s little doubt that Skinvisible is treading the right path.
Since 1999, pharmaceutical and cosmeceutical companies have been adopting Skinvisible’s Invisicare® technology, developed through wholly-owned subsidiary Skinvisible Pharmaceuticals, Inc. The technology can be used to revitalize or create new medical or skincare products, allowing a company that licenses Skinvisible’s formulations to sell its own patented product and combat generic competitors.
Products utilizing Invisicare have been effective at bonding active ingredients to the skin for up to four hours and longer. Invisicare is non-occlusive; it allows normal skin respiration and perspiration while moisturizing and protecting against exposure from a wide variety of environmental irritants. When topically applied, products formulated with Invisicare adhere to the skin’s outer layers, forming a protective bond, resisting wash-off and delivering targeted levels of therapeutic or cosmetic skincare agents to the skin. This allows enhanced delivery performance for a variety of topicals resulting in improved efficacy, longer duration of action, reduced irritation and lower dosage of active agents required. The ‘invisible’ polymer compositions that make up Invisicare wear off as part of the natural exfoliation process that removes the skin’s outer layer of cells.
With a $80 billion global dermatology market and a $30 billion global over-the-counter skincare market, the patented polymer delivery system for topical products developed by Skinvisible has a great deal of potential to add shareholder value.
For more information, visit the company’s website at www.Skinvisible.com
Let us hear your thoughts: Skinvisible, Inc. Message Board
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – RJD Green, Inc. (RJDG) Enters Formal Discussions for Acquisition of Operating Oil & Gas Properties

Multi-division holding company RJD Green, Inc. (OTC: RJDG) today announced that its Earthlinc Environmental division has entered into formal discussions regarding the acquisition of two operating oil and gas properties strategically located in the Mid-America region. Per the update, the combined properties reflect over 4,700 contiguous acres with existing production and net operating profit of over $33,000 per month. The company projects that, with secondary enhancement of existing wells and an orderly drilling and completion program, revenue from the properties could grow ten-fold. “We hope to have reached terms of acquisition within thirty days,” RJD Green management noted in a joint statement. “If an LOI agreement is reached, the targeted closing date would be within ninety days of reaching a letter of intent.”
To view the full press release, visit http://ibn.fm/V88qM
Let us hear your thoughts: RJD Green Inc. Message Board
About RJD Green, Inc.
The company operates as a holding company with a focus of acquiring and managing assets and companies. RJD Green operates in three divisions: RJD Green Healthcare Services Division, which owns IOSOFT Inc, a company that provides discrete payment technologies, services and software that can be integrated into targeted offerings for healthcare provider networks, hospitals, healthcare payers and individual providers: Earthlinc Environmental Services Division, which provides green environmental services and technologies; Silex Holdings Division, which is engaged in specialty construction and industrial manufacturing and fills a market niche between the Home Depots and local contractors. Silex offers installed granite/other counter tops, cabinets and related products to the residential builder, commercial contractor, remodel contractor and retail customer. For more information, visit the company’s website at www.RJDGreen.com
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Diversifies Methods of Reaching Global Chinese-speaking Audience

Market analysis company ChineseInvestors.com (OTCQB: CIIX) uses a variety of methods to reach its global Chinese-speaking audience. Such methods include a daily video broadcast from the NYSE on cryptocurrencies and the company’s development of a new social media mobile app for the cannabis industry. An article discussing the company reads: “ChineseInvestors.com, Inc. (OTCQB: CIIX) is reaching out to the global Chinese-speaking community through both daily video broadcasts on cryptocurrencies and, soon, a new mobile app focused on reviews and discussion of cannabis products. CIIX is involved in both product areas. The company is a diverse educational and consulting firm targeting the Chinese-speaking community in both China and the U.S. …In cryptocurrencies such as bitcoin, the company is active in educational activities, produces a daily video broadcast from the NYSE titled ‘Bitcoin MultiMillionaire’ and hosts a Bitcoin ATM in the lobby of its San Gabriel, California, headquarters.”
To view the full article, visit http://ibn.fm/At69z
Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board
About ChineseInvestors.com
Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail and online sales of hemp-based products and other health related products. For more information visit www.ChineseInvestors.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Medical Cannabis Payment Solutions (REFG) Helps Fill State Coffers

  • States that legalize medical cannabis reaping large tax windfalls
  • State-sanctioned cannabis businesses forced into cash-only operation due to federal banking impasse
  • REFG resolves cannabis banking and operational issues, generating more state tax revenues
Current regulatory anxiety surrounding cannabis will have little impact on the long-term growth of the industry. Evermore states continue to relax marijuana strictures not only in response to citizen demand but also to generate tax revenues. There’s overwhelming scientific evidence validating the medical efficacy of certain cannabinoids, and states that have legalized marijuana in various forms are finding that cannabis cash is filling state coffers. In 2016, marijuana tax revenue totaled $256 million in Washington and $60 million in Oregon. Meanwhile, Colorado has harvested over half a billion dollars in taxes and fees since it legalized recreational weed. In a report from New Frontier Data highlighted in Forbes (http://ibn.fm/nHpjI), tax revenues in states with legalized marijuana were estimated at $1.8 billion last year. States are addicted to cannabis tax revenues and more states will look to legalization to increase income.
The states’ need and subsequent reliance on marijuana tax revenues pits state rights against federal oversight. This ongoing impasse has created a banking conundrum and an enormous opportunity for Medical Cannabis Payment Solutions (OTC: REFG). Banks are licensed and regulated by the federal government and, subsequently, are reluctant to accept proceeds from any marijuana operation. Medical Cannabis Payment Solutions delivers solutions to state-sanctioned medical cannabis operations, providing end-to-end management across multiple management systems. REFG resolves all the fragmentation issues created by the federal government impasse and rapid industry growth.
REFG delivers an industry first, secure, state-of-the-art financial services system that’s simple to set up and easy to use. The company’s purpose-built solution to cannabis banking solves cash handling issues, offers electronic payment and e-commerce features and gives marijuana businesses immediate access to funds while keeping them in compliance with all federal (FinCEN) laws aimed at combatting domestic and international money laundering, terrorist financing and other financial crimes. Not only compliant, REFG’s end-to-end payment processing solution finally provides cannabis customers and retailers with payment options other than cash.
REFG’s proprietary ‘StateSourced” closed-loop merchant processing system is the first operation of its kind geared to the legal cannabis industry. Not a prepaid or gift card, it is one of the first and only comprehensive card processing operations to break the operational and logistical logjam caused by cash-only transactions in state-sanctioned marijuana businesses. The debit card from Medical Cannabis Payment Solutions can only be used for payment within a state where marijuana is legal and only for cannabis-related products from state-sanctioned vendors. Businesses using the company’s card realize an immediate advantage in reducing risks, meeting regulatory requirements and improving customer interactions.
There’s no longer any doubt about the medical efficacy of certain cannabinoids. State-sanctioned delivery of these medications will not only continue but is likely to expand due to patient needs and the states’ increasing reliance on the massive influx of cannabis tax revenues.
For more information, visit the company’s website at www.MedicalCannabisPaymentSolutions.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php